Minimal SARS-CoV-2 diversity suggests a global vaccine is feasible

(Walter Reed Army Institute of Research) Genetic analysis of sequences from more than 27,000 individuals infected with the coronavirus that causes COVID-19 reveals that the virus has mutated minimally since December 2019, suggesting one vaccine would be sufficient to combat global infections.